Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells

Recent evidence suggests that the development of castration resistant prostate cancer (CRPCa) is commonly associated with an aberrant, ligand-independent activation of the androgen receptor (AR). A putative mechanism allowing prostate cancer (PCa) cells to grow under low levels of androgens, is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zengerling, Friedemann, Streicher, Wolfgang, Schrader, Andres J., Schrader, Mark, Nitzsche, Bianca, Cronauer, Marcus V., Höpfner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472761/
https://www.ncbi.nlm.nih.gov/pubmed/23109869
http://dx.doi.org/10.3390/ijms130911530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472761/
https://www.ncbi.nlm.nih.gov/pubmed/23109869
http://dx.doi.org/10.3390/ijms130911530

Ejemplares similares